BUBENDORF, SWITZERLAND: Carbogen Amcis AG has named Mark C Griffiths as the new Chief Executive Officer of the company. In his new role, Griffiths will be responsible for Carbogen Amcis’ Swiss business and will report to Jay Vyas, Managing Director of Dishman Pharmaceuticals and Chemicals Ltd, Carbogen Amcis’ parent company.
Mark C Griffiths has been associated with Carbogen Amcis as Director of Operations and CEO for almost ten years. Most recently, he has been working for the Dishman Group as operations advisor overseeing the design and construction of the group’s large-scale manufacturing facilities for commercial supply of highly potent APIs in Shanghai, China and Ahmedabad, India.
“We are delighted that Mark agreed to join Carbogen Amcis as CEO. Mark’s industrial expertise and proven track record in the pharmaceutical industry make him the ideal executive to lead Carbogen Amcis’ growth,” commented Jay Vyas.
Griffiths has over 28 years of relevant industrial experience within the pharmaceutical and fine chemical industry. Qualified as an engineer, he brings a cross-functional ability to anticipate and optimize technical, operational and management issues.
© WOC News